Drug policy
Drug Tests and the Prediction of Pretrial Misconduct: Findings and Policy Issues
Europe Meets U.S. in Crime and Policy
Impact of Drug Treatment on Recidivism - Do Mandatory Programs Make a Difference? Evidence From Kansas's Senate Bill 123
Racial/Ethnic Disparities in Arrests For Drug Possession After California Proposition 47, 2011-2016 American Journal of Public Health
Office of Justice Programs (OJP) / Centers for Disease Control and Prevention (CDC) Federal Medicolegal Death Investigation Interagency Working Group (MDI-IWG) Resource Page
The Department of Justice’s (DOJ) Office of Justice Programs (OJP) and the U.S. Health and Human Services’ (HHS) Center for Disease Control and Prevention (CDC) established this Federal Medicolegal Death Investigation (MDI) Interagency Working Group (MDI-IWG) to coordinate Federal initiatives to strengthen MDI systems and support death investigation services practiced by medical examiner and coroner offices (MECs) across the United States. The MDI-IWG commenced in...
State Administering Agencies
Many OJP formula grants are awarded directly to state governments, which then set priorities and allocate funds within that state. For more information on how a state intends to distribute formula grant funds, contact the administering state agency. For each state, a list of formula grant points of contact is available by clicking on that state in the map below, or choosing from the drop menu at the bottom of the page. If you are using grant monies for information technology, you can comply with the special condition by contacting the State and Territory Technology Points of Contact in your state